Regulatory Status: Not FDA-Approved Its important to understand that 5-Amino-1MQ is not an FDA-approved drug
It's crucial to inform your healthcare provider about any existing health conditions, medications, or supplements you're taking to ensure the treatment is safe for you
The FDA enforcement-discretion period that allowed mass compounding during the tirzepatide shortage ended on March 19, 2025 for 503B outsourcing facilities and February 18, 2025 for 503A pharmacies
Discuss your medical history, goals, and any existing conditions that could influence safe peptide use
Some notice burning, cold sensitivity, or sharp zaps at night
Look for sourcing from a licensed US compounding pharmacy, a licensed provider who screens candidacy, honest framing that AOD 9604 is not FDA-approved, and progress measured by body composition and labs